GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pulse Biosciences Inc (STU:6L8) » Definitions » Cyclically Adjusted FCF per Share

Pulse Biosciences (STU:6L8) Cyclically Adjusted FCF per Share : €-1.26 (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Pulse Biosciences Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Pulse Biosciences's adjusted free cash flow per share for the three months ended in Dec. 2024 was €-0.141. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-1.26 for the trailing ten years ended in Dec. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2025-05-07), Pulse Biosciences's current stock price is €14.10. Pulse Biosciences's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2024 was €-1.26. Pulse Biosciences's Cyclically Adjusted Price-to-FCF of today is .


Pulse Biosciences Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Pulse Biosciences's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pulse Biosciences Cyclically Adjusted FCF per Share Chart

Pulse Biosciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -1.26

Pulse Biosciences Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -1.19 -1.26

Competitive Comparison of Pulse Biosciences's Cyclically Adjusted FCF per Share

For the Medical Instruments & Supplies subindustry, Pulse Biosciences's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pulse Biosciences's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pulse Biosciences's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Pulse Biosciences's Cyclically Adjusted Price-to-FCF falls into.


;
;

Pulse Biosciences Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pulse Biosciences's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.141/133.1571*133.1571
=-0.141

Current CPI (Dec. 2024) = 133.1571.

Pulse Biosciences Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201503 -0.055 99.621 -0.074
201506 -0.067 100.684 -0.089
201509 -0.110 100.392 -0.146
201512 -0.159 99.792 -0.212
201603 -0.105 100.470 -0.139
201606 -0.207 101.688 -0.271
201609 -0.131 101.861 -0.171
201612 -0.162 101.863 -0.212
201703 -0.166 102.862 -0.215
201706 -0.074 103.349 -0.095
201709 -0.196 104.136 -0.251
201712 -0.198 104.011 -0.253
201803 -0.239 105.290 -0.302
201806 -0.292 106.317 -0.366
201809 -0.345 106.507 -0.431
201812 -0.310 105.998 -0.389
201903 -0.310 107.251 -0.385
201906 -0.410 108.070 -0.505
201909 -0.365 108.329 -0.449
201912 -0.390 108.420 -0.479
202003 -0.418 108.902 -0.511
202006 -0.319 108.767 -0.391
202009 -0.285 109.815 -0.346
202012 -0.304 109.897 -0.368
202103 -0.372 111.754 -0.443
202106 -0.507 114.631 -0.589
202109 -0.381 115.734 -0.438
202112 -0.376 117.630 -0.426
202203 -0.476 121.301 -0.523
202206 -0.379 125.017 -0.404
202209 -0.286 125.227 -0.304
202212 -0.199 125.222 -0.212
202303 -0.162 127.348 -0.169
202306 -0.185 128.729 -0.191
202309 -0.173 129.860 -0.177
202312 -0.110 129.419 -0.113
202403 -0.160 131.776 -0.162
202406 -0.137 132.554 -0.138
202409 -0.134 133.029 -0.134
202412 -0.141 133.157 -0.141

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Pulse Biosciences  (STU:6L8) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Pulse Biosciences Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Pulse Biosciences's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Pulse Biosciences Business Description

Traded in Other Exchanges
Address
601 Brickell Key Drive, Suite 1080, Miami, FL, USA, 33131
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

Pulse Biosciences Headlines

No Headlines